Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-22 @ 7:15 AM
Study NCT ID:
NCT00485758
Status:
COMPLETED
Last Update Posted:
2015-10-12
First Post:
2007-06-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-12
First Submit QC Date:
None
Study First Post Date:
2007-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-08-04
Results First Submit QC Date:
None
Results First Post Date:
2009-09-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-09
Last Update Post Date:
2015-10-12
Last Update Post Date Type:
ESTIMATED